Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-20 of 40

Sort by

Sort Order Select

Journal Articles

Correction: Mesenchymal-Type Neuroblastoma Cells Escape ALK Inhibitors

Cancer Res (2022) 82 (14): 2657.

https://doi.org/10.1158/0008-5472.CAN-22-1915

Published: 18 July 2022

View article titled, Correction: Mesenchymal-Type Neuroblastoma Cells Escape ALK Inhibitors

Journal Articles

Mesenchymal-Type Neuroblastoma Cells Escape ALK Inhibitors

Cancer Res (2022) 82 (3): 484–496.

https://doi.org/10.1158/0008-5472.CAN-21-1621

Published: 02 February 2022

View article titled, Mesenchymal-Type Neuroblastoma Cells Escape ALK Inhibitors

Includes: Supplementary data

Journal Articles

Abstract SY24-02: Neuroblastoma: A developmental twist

Rogier Versteeg, Linda Valentijn, Jan Koster, Tim van Groningen, Mohamed Hamdi, Ellen Westerhout, Johan van Nes

Cancer Res (2019) 79 (13_Supplement): SY24-02.

https://doi.org/10.1158/1538-7445.AM2019-SY24-02

Published: 01 July 2019

View article titled, Abstract SY24-02: Neuroblastoma: A developmental twist

Journal Articles

Abstract 3662: Plasticity of transcriptional and epigenetic cellular states in neuroblastoma is driven by core lineage transcription factors

Johan van Nes, Tim van Groningen, Linda Valentijn, Danny Zwijnenburg, Ellen M. Westerhout, Mohamed Hamdi, Jan Koster, Rogier Versteeg

Cancer Res (2019) 79 (13_Supplement): 3662.

https://doi.org/10.1158/1538-7445.AM2019-3662

Published: 01 July 2019

View article titled, Abstract 3662: Plasticity of transcriptional and epigenetic cellular states in neuroblastoma is driven by core lineage transcription factors

Journal Articles

Abstract 2490: R2: Genomics analysis and visualization platform

Jan Koster, Richard Volckmann, Danny Zwijnenburg, Piet Molenaar, Rogier Versteeg

Cancer Res (2019) 79 (13_Supplement): 2490.

https://doi.org/10.1158/1538-7445.AM2019-2490

Published: 01 July 2019

View article titled, Abstract 2490: R2: Genomics analysis and visualization platform

Journal Articles

RAS–MAPK Pathway-Driven Tumor Progression Is Associated with Loss of CIC and Other Genomic Aberrations in Neuroblastoma

Thomas F. Eleveld, Linda Schild, Jan Koster, Danny A. Zwijnenburg, Lindy K. Alles, Marli E. Ebus, Richard Volckmann, Godelieve A. Tijtgat, Peter van Sluis, Rogier Versteeg, Jan J. Molenaar

Cancer Res (2018) 78 (21): 6297–6307.

https://doi.org/10.1158/0008-5472.CAN-18-1045

Published: 01 November 2018

View article titled, RAS–MAPK Pathway-Driven Tumor Progression Is Associated with Loss of CIC and Other Genomic Aberrations in Neuroblastoma

Includes: Supplementary data

Journal Articles

Abstract IA10: Neuroblastoma is a biphasic tumor

Rogier Versteeg, Tim van Groningen, Jan Koster, Linda J. Valentijn, Johan van Nes

Cancer Res (2018) 78 (19_Supplement): IA10.

https://doi.org/10.1158/1538-7445.PEDCA17-IA10

Published: 01 October 2018

View article titled, Abstract IA10: Neuroblastoma is a biphasic tumor

Journal Articles

Abstract 4131: Plasticity of transcriptional and epigenetic cellular states in neuroblastoma is driven by core lineage transcription factors

Johan V. Nes, Tim V. Groningen, Jan Koster, Linda Valentijn, Danny Zwijnenburg, Ellen M. Westerhout, Mohamed Hamdi, Rogier Versteeg

Cancer Res (2018) 78 (13_Supplement): 4131.

https://doi.org/10.1158/1538-7445.AM2018-4131

Published: 01 July 2018

View article titled, Abstract 4131: Plasticity of transcriptional and epigenetic cellular states in neuroblastoma is driven by core lineage transcription factors

Journal Articles

Abstract 3876: Active enhancers delineate intra-tumor heterogeneity of developmental states in neuroblastoma

Johan van Nes, Tim van Groningen, Linda J. Valentijn, Danny Zwijnenburg, Jan J. Molenaar, Bart A. Westerman, Ellen M. Westerhout, Mohamed Hamdi, Godelieve A. Tytgat, Jan Koster, Rogier Versteeg

Cancer Res (2017) 77 (13_Supplement): 3876.

https://doi.org/10.1158/1538-7445.AM2017-3876

Published: 01 July 2017

View article titled, Abstract 3876: Active enhancers delineate intra-tumor heterogeneity of developmental states in neuroblastoma

Journal Articles

Abstract 2453: Neuroblastoma is bi-phasic and includes classical neuro-epithelial cells and chemo-resistant mesenchymal cells

Rogier Versteeg, Tim van Groningen, Linda J. Valentijn, Bart A. Westerman, Jan J. Molenaar, Ellen M. Westerhout, Mohamed Hamdi, Godelieve A. Tytgat, Jan Koster, Johan van Nes.

Cancer Res (2016) 76 (14_Supplement): 2453.

https://doi.org/10.1158/1538-7445.AM2016-2453

Published: 15 July 2016

View article titled, Abstract 2453: Neuroblastoma is bi-phasic and includes classical neuro-epithelial cells and chemo-resistant mesenchymal cells

Journal Articles

Abstract B09: MCL-1 inhibition improves ABT199 efficacy for BCL-2-dependent neuroblastoma

Laurel T. Bate-Eya, Ilona J.M. den Hartog, Ida van der Ploeg, Linda Schild, Jan Koster, Rogier Versteeg, Huib N. Caron, Jan J. Molenaar, M. Emmy M. Dolman

Cancer Res (2016) 76 (5_Supplement): B09.

https://doi.org/10.1158/1538-7445.PEDCA15-B09

Published: 04 April 2016

View article titled, Abstract B09: MCL-1 inhibition improves ABT199 efficacy for BCL-2-dependent neuroblastoma

Journal Articles

Abstract PR08: Neuroblastoma is biphasic and includes classical neuroepithelial cells and chemoresistant mesenchymal cells

Rogier Versteeg, Tim van Groningen, Bart A. Westerman, Jan J. Molenaar, Ellen M. Westerhout, Mohamed Hamdi, Godelieve A. Tytgat, Jan Koster, Johan van Nes

Cancer Res (2016) 76 (5_Supplement): PR08.

https://doi.org/10.1158/1538-7445.PEDCA15-PR08

Published: 04 April 2016

View article titled, Abstract PR08: Neuroblastoma is biphasic and includes classical neuroepithelial cells and chemoresistant mesenchymal cells

Journal Articles

Abstract PR06: TERT rearrangements are frequent in neuroblastoma and identify aggressive tumors

Jan Koster, Linda J. Valentijn, Danny A. Zwijnenburg, Nancy E. Hasselt, Peter G. van Sluis, Max M. van Noesel, Rani E. George, Godelieve A. Tytgat, Jan J. Molenaar, Rogier Versteeg

Cancer Res (2016) 76 (5_Supplement): PR06.

https://doi.org/10.1158/1538-7445.PEDCA15-PR06

Published: 04 April 2016

View article titled, Abstract PR06: TERT rearrangements are frequent in neuroblastoma and identify aggressive tumors

Journal Articles

Abstract A2-45: R2: Accessible web-based genomics analysis and visualization platform for biomedical researchers

Jan Koster, Jan J. Molenaar, Rogier Versteeg

Cancer Res (2015) 75 (22_Supplement_1): A2-45.

https://doi.org/10.1158/1538-7445.TRANSCAGEN-A2-45

Published: 15 November 2015

View article titled, Abstract A2-45: R2: Accessible web-based genomics analysis and visualization platform for biomedical researchers

Journal Articles

Abstract B1-05: R2: Accessible web-based genomics analysis and visualization platform for biomedical researchers

Jan Koster, Jan J. Molenaar, Rogier Versteeg

Cancer Res (2015) 75 (22_Supplement_2): B1-05.

https://doi.org/10.1158/1538-7445.COMPSYSBIO-B1-05

Published: 15 November 2015

View article titled, Abstract B1-05: R2: Accessible web-based genomics analysis and visualization platform for biomedical researchers

Journal Articles

Abstract LB-209: Neuroblastoma is biphasic with classical neuro-epithelial cells and chemoresistant mesenchymal cells controlled by PRRX1-NOTCH signaling

Tim van Groningen, Natalia E. Nowakowska, Nurdan Akogul, Marloes Broekmans, Johannes Bras, Jan Booij, Marli E. Ebus, Jan J. Molenaar, Ellen M. Westerhout, Mohamed Hamdi, Peter van Sluis, Jan Koster, Bart A. Westerman, Godelieve A. Tytgat, Rogier Versteeg, Johan van Nes

Cancer Res (2015) 75 (15_Supplement): LB-209.

https://doi.org/10.1158/1538-7445.AM2015-LB-209

Published: 01 August 2015

View article titled, Abstract LB-209: Neuroblastoma is biphasic with classical neuro-epithelial cells and chemoresistant mesenchymal cells controlled by PRRX1-NOTCH signaling

Journal Articles

Abstract 2980: Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations

Cancer Res (2015) 75 (15_Supplement): 2980.

https://doi.org/10.1158/1538-7445.AM2015-2980

Published: 01 August 2015

View article titled, Abstract 2980: Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations

Journal Articles

Abstract B41: Whole genome sequencing identifies tumor evolution events in relapse neuroblastoma

Thomas F. Eleveld, Linda Schild, Jan Koster, Danny Zwijnenburg, Marli E. Ebus, Peter Sluis van, Johannes H. Schulte, Huib N. Caron, Rogier Versteeg, Jan J. Molenaar

Cancer Res (2014) 74 (20_Supplement): B41.

https://doi.org/10.1158/1538-7445.PEDCAN-B41

Published: 09 October 2014

View article titled, Abstract B41: Whole genome sequencing identifies tumor evolution events in relapse neuroblastoma

Journal Articles

Selection of Personalized Patient Therapy through the Use of Knowledge-Based Computational Models That Identify Tumor-Driving Signal Transduction Pathways

Wim Verhaegh, Henk van Ooijen, Márcia A. Inda, Pantelis Hatzis, Rogier Versteeg, Marcel Smid, John Martens, John Foekens, Paul van de Wiel, Hans Clevers, Anja van de Stolpe

Cancer Res (2014) 74 (11): 2936–2945.

https://doi.org/10.1158/0008-5472.CAN-13-2515

Published: 29 May 2014

View article titled, Selection of Personalized Patient Therapy through the Use of Knowledge-Based Computational Models That Identify Tumor-Driving Signal Transduction Pathways

Includes: Supplementary data

Journal Articles

Histone Chaperone CHAF1A Inhibits Differentiation and Promotes Aggressive Neuroblastoma

Eveline Barbieri, Katleen De Preter, Mario Capasso, Zaowen Chen, Danielle M. Hsu, Gian Paolo Tonini, Steve Lefever, John Hicks, Rogier Versteeg, Andrea Pession, Frank Speleman, Eugene S. Kim, Jason M. Shohet

Cancer Res (2014) 74 (3): 765–774.

https://doi.org/10.1158/0008-5472.CAN-13-1315

Published: 02 February 2014

View article titled, Histone Chaperone CHAF1A Inhibits Differentiation and Promotes Aggressive Neuroblastoma

Includes: Supplementary data

NARROW

Correction: Mesenchymal-Type Neuroblastoma Cells Escape ALK Inhibitors

Mesenchymal-Type Neuroblastoma Cells Escape ALK Inhibitors

Abstract SY24-02: Neuroblastoma: A developmental twist

Abstract 3662: Plasticity of transcriptional and epigenetic cellular states in neuroblastoma is driven by core lineage transcription factors

Abstract 2490: R2: Genomics analysis and visualization platform

RAS–MAPK Pathway-Driven Tumor Progression Is Associated with Loss of CIC and Other Genomic Aberrations in Neuroblastoma

Abstract IA10: Neuroblastoma is a biphasic tumor

Abstract 4131: Plasticity of transcriptional and epigenetic cellular states in neuroblastoma is driven by core lineage transcription factors

Abstract 3876: Active enhancers delineate intra-tumor heterogeneity of developmental states in neuroblastoma

Abstract 2453: Neuroblastoma is bi-phasic and includes classical neuro-epithelial cells and chemo-resistant mesenchymal cells

Abstract B09: MCL-1 inhibition improves ABT199 efficacy for BCL-2-dependent neuroblastoma

Abstract PR08: Neuroblastoma is biphasic and includes classical neuroepithelial cells and chemoresistant mesenchymal cells

Abstract PR06: TERT rearrangements are frequent in neuroblastoma and identify aggressive tumors

Abstract A2-45: R2: Accessible web-based genomics analysis and visualization platform for biomedical researchers

Abstract B1-05: R2: Accessible web-based genomics analysis and visualization platform for biomedical researchers

Abstract LB-209: Neuroblastoma is biphasic with classical neuro-epithelial cells and chemoresistant mesenchymal cells controlled by PRRX1-NOTCH signaling

Abstract 2980: Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations

Abstract B41: Whole genome sequencing identifies tumor evolution events in relapse neuroblastoma

Selection of Personalized Patient Therapy through the Use of Knowledge-Based Computational Models That Identify Tumor-Driving Signal Transduction Pathways

Histone Chaperone CHAF1A Inhibits Differentiation and Promotes Aggressive Neuroblastoma

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only